7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 
      
    		                                                                 
      operating activities:
    		                                                                 
      net income
    		4,151,000 11,305,000 4,049,000 102,723,000 -2,998,000 7,640,000 915,000 -3,893,000 5,420,000 18,197,000 6,033,000 -1,904,000 256,000 1,725,000 7,719,000 -1,178,000 2,513,000 -6,780,000 109,047,000 -29,992,000 -21,598,000 -36,967,000 -10,376,000 -114,645,000 -18,209,000 -8,546,000 -19,100,000 2,732,000 -12,056,000 -12,153,000 -62,763,000 -34,974,000 -1,338,000 -14,619,000 -11,252,000 -38,410,000 -24,028,000 -29,224,000 -147,731,000 -231,946,000 10,736,000 15,365,000 -3,622,000 -147,468,000 -12,467,000 -1,550,000 -6,090,000 -9,121,000 12,854,000 12,181,000 1,147,000 -24,490,000 1,954,000 30,469,000 -2,515,000 -62,875,000 170,000 13,560,000 5,427,000 25,805,000 22,662,000 9,175,000 11,162,000 -59,897,000 11,657,000 
      reconciliation of net income to net cash from operating activities:
    		                                                                 
      depreciation, amortization and accretion
    		9,491,000 9,189,000 9,151,000                                                               
      impairments and other charges
    		0 93,000 518,000 0                                                              
      gain on investments
    		  -257,000       -908,000 505,000  549,000 710,000 -1,100,000                                                   
      equity-based compensation expense
    		1,708,000 1,747,000 1,860,000 1,668,000 1,481,000 1,800,000 1,623,000 6,423,000 1,431,000 1,492,000 1,276,000 3,519,000 1,098,000 1,159,000 1,104,000 1,053,000 1,057,000 76,000 2,478,000 1,769,000 1,951,000 2,112,000 784,000 1,867,000 1,328,000 2,767,000 2,165,000 1,687,000 2,270,000 2,546,000 876,000 485,000 1,798,000 2,975,000 2,469,000 2,198,000 2,548,000 6,628,000 2,373,000 9,071,000 3,619,000 2,601,000 1,596,000 1,966,000 1,536,000 1,418,000 1,855,000 1,611,000 1,489,000 1,898,000 2,355,000               
      recovery of credit losses
    		13,000 -32,000 -85,000    -115,000                                                           
      amortization and expense of financing costs
    		506,000 484,000 495,000 266,000 239,000 504,000 380,000 726,000 926,000 897,000 884,000 998,000 805,000 793,000 780,000     1,554,000 943,000 2,186,000 569,000                                           
      loss on debt extinguishment
    		   0 0                                                             
      gain on sale of assets
    		-66,000 -23,000 -113,000 -196,000 -75,000 -38,000 -29,000 -130,000 -151,000 -111,000 -170,000 -190,000 -261,000 -501,000 -218,000 -3,000 -204,000 -20,000 -255,000 -328,000 -2,321,000 -1,186,000 -833,000 -750,000 -711,000 -671,000 -201,000  -389,000 -155,000 90,000  -72,000 -450,000 -83,000  -386,000 -837,000 -1,019,000  -350,000 -656,000 -1,650,000  -309,000 -137,000 -102,000  -5,486,000                 
      non-cash cumulative foreign currency translation adjustment income from dissolution of canadian subsidiary
    		0 0 9,516,000                                                               
      deferred income tax expense
    		                                                                 
      other non-cash credits
    		-254,000 -96,000 -128,000   -133,000 -553,000  -179,000 -637,000 -100,000                                                       
      changes in operating assets and liabilities:
    		                                                                 
      accounts receivable
    		-6,345,000 11,089,000 -15,584,000 2,693,000 26,634,000 -4,020,000 -19,605,000 12,565,000 8,114,000 -13,140,000 12,626,000 -23,187,000 -2,080,000 -1,396,000 -13,185,000 -12,549,000 448,000 -17,195,000 1,501,000 1,255,000 6,487,000 51,226,000 3,601,000 -6,838,000 20,384,000 -9,428,000 2,353,000 2,196,000 -7,662,000 -6,630,000 6,584,000 -21,010,000 -3,217,000 -20,061,000 -10,909,000 4,515,000 -10,596,000 -3,916,000 74,328,000 23,597,000 -16,709,000 -1,561,000 32,698,000 7,042,000 -25,106,000 -10,063,000 20,261,000 17,697,000 -23,274,000 -22,471,000 -16,232,000 19,670,000 -4,138,000 -2,909,000 3,506,000 1,991,000 6,424,000 -6,295,000 4,493,000 67,751,000 -12,158,000 -10,478,000 17,249,000   
      inventories
    		2,968,000 574,000 -2,663,000 -6,826,000 -13,953,000 10,453,000 1,542,000 -3,215,000 -11,441,000 2,764,000 -11,313,000 1,236,000 -10,226,000 -60,000 4,579,000 2,938,000 -3,007,000 4,958,000 498,000 5,203,000 1,047,000 23,147,000 -12,414,000 4,077,000 -6,755,000 15,717,000 -15,809,000 6,699,000 -17,522,000 -4,931,000 -13,467,000 2,062,000 -2,704,000 -63,000 -10,627,000 20,577,000 -4,995,000 844,000 -15,042,000 27,950,000 36,333,000 18,785,000 -12,637,000 -16,401,000 -14,106,000 5,675,000 3,304,000 -7,862,000 1,625,000 3,546,000 -3,226,000 -3,848,000 -5,806,000 4,401,000 7,411,000 7,014,000 -2,151,000 8,862,000 3,583,000 -4,414,000 -5,694,000 1,031,000 4,449,000 5,440,000 -5,951,000 
      prepaid expenses and other current assets
    		-66,000 -1,496,000 6,158,000 -5,344,000 1,930,000 758,000 -3,918,000 863,000 -929,000 -2,254,000 4,496,000 -764,000 -1,500,000 -4,792,000 2,510,000 -3,606,000 -485,000 -1,382,000 -1,060,000 2,588,000 2,122,000 -596,000 -2,442,000 2,410,000 2,496,000 -1,105,000 -3,222,000 -893,000 -561,000 1,877,000 -4,311,000 51,000 324,000 -1,456,000 -527,000 -375,000 1,586,000 3,787,000 -1,650,000 -971,000 1,257,000 -2,865,000 773,000 -2,849,000 -1,168,000 5,981,000 -2,161,000 -5,077,000 2,668,000 3,630,000 1,772,000 -2,975,000 -2,530,000 13,036,000 15,916,000 1,495,000 -3,030,000 5,275,000 -5,832,000 5,510,000 3,067,000 5,013,000 21,000 -14,505,000 2,253,000 
      trade accounts payable and accrued expenses
    		4,110,000 11,033,000 -9,277,000 1,744,000 606,000 -913,000 -5,577,000 -3,021,000 2,450,000 11,622,000 -11,179,000 5,636,000 5,884,000 11,176,000 9,000 1,775,000 3,936,000 12,774,000 8,521,000 -4,430,000 -14,991,000 -51,595,000 8,742,000 -26,889,000 5,578,000 -1,872,000 6,638,000 12,239,000 16,470,000 1,340,000 -24,586,000 30,569,000 13,763,000 31,524,000 -16,919,000 1,297,000 -13,923,000 -9,969,000 -33,176,000 -10,499,000 -44,829,000 -16,769,000 -26,310,000 41,310,000 19,662,000 -7,227,000 13,763,000 -17,320,000 10,080,000 4,330,000 4,659,000 -289,000 -12,087,000 10,617,000 -28,225,000 2,900,000 11,272,000 4,124,000 -23,796,000 -13,262,000 -19,086,000 29,665,000 -27,939,000 1,641,000 -40,940,000 
      other
    		531,000 1,159,000 295,000 150,000 -3,313,000 103,000 26,000 -1,411,000 530,000 475,000 128,000 -1,787,000 -689,000 -926,000 -153,000 -1,120,000 -1,017,000 -933,000 -478,000 -1,923,000 642,000 1,630,000 -1,384,000 -1,024,000 -1,642,000 -1,093,000 -499,000 668,000 -2,104,000 95,000 -732,000 -1,352,000 145,000 533,000 -666,000 885,000 -468,000 98,000 -1,009,000 -135,000 -94,000 3,959,000 -842,000 -1,076,000 -61,000 -1,604,000 -735,000 -56,000 -268,000 1,024,000 599,000 -383,000 -577,000 3,335,000 524,000 -1,666,000 662,000 -6,000 999,000    382,000 -1,552,000 921,000 
      net cash from operating activities
    		16,366,000 48,333,000 3,935,000 5,635,000 19,870,000 24,831,000 -13,816,000 18,875,000 13,974,000 28,372,000 8,985,000 -6,991,000 2,145,000 17,869,000 5,934,000 -5,767,000 2,817,000 1,782,000 5,825,000 12,085,000 4,440,000 38,211,000 22,176,000 5,250,000 46,605,000 30,965,000 7,412,000 44,953,000 13,760,000 19,134,000 -31,261,000 27,761,000    28,316,000 -7,933,000 8,336,000 25,261,000 77,724,000 36,065,000 54,347,000 27,815,000 56,708,000 11,317,000 4,550,000 36,070,000 5,749,000 13,546,000   -4,596,000 -11,531,000 29,547,000 30,367,000 33,965,000 28,906,000 38,602,000 51,852,000 135,018,000 7,306,000 90,135,000 39,856,000 10,069,000 65,640,000 
      capex
    		-15,739,000 -19,487,000 -17,956,000 -14,888,000 -14,573,000 -15,392,000 -15,827,000 -7,912,000 -6,966,000 -10,490,000 -12,784,000 -7,378,000 -12,266,000 -11,107,000 -9,305,000 -5,913,000 -2,131,000 -5,728,000 -6,761,000 -7,375,000 -2,403,000 -7,218,000 -12,390,000 -19,081,000 -28,588,000 -28,195,000 -32,409,000 -34,851,000 -39,639,000 -38,549,000 -28,892,000 -23,336,000    -5,628,000 -6,442,000 -5,765,000 -3,231,000 -24,454,000 -22,874,000 -24,245,000 -49,024,000 -47,474,000 -31,895,000 -23,405,000 -28,835,000 -27,824,000 -22,020,000   -23,747,000 -63,573,000 -16,965,000 -19,319,000 -25,496,000 -48,322,000 -23,020,000 -10,846,000 0 -32,670,000 -39,791,000 -55,570,000 -57,183,000 -72,971,000 
      free cash flows
    		627,000 28,846,000 -14,021,000 -9,253,000 5,297,000 9,439,000 -29,643,000 10,963,000 7,008,000 17,882,000 -3,799,000 -14,369,000 -10,121,000 6,762,000 -3,371,000 -11,680,000 686,000 -3,946,000 -936,000 4,710,000 2,037,000 30,993,000 9,786,000 -13,831,000 18,017,000 2,770,000 -24,997,000 10,102,000 -25,879,000 -19,415,000 -60,153,000 4,425,000    22,688,000 -14,375,000 2,571,000 22,030,000 53,270,000 13,191,000 30,102,000 -21,209,000 9,234,000 -20,578,000 -18,855,000 7,235,000 -22,075,000 -8,474,000   -28,343,000 -75,104,000 12,582,000 11,048,000 8,469,000 -19,416,000 15,582,000 41,006,000 135,018,000 -25,364,000 50,344,000 -15,714,000 -47,114,000 -7,331,000 
      investing activities:
    		                                                                 
      purchases of property, plant and equipment
    		-15,739,000 -19,487,000 -17,956,000                                                          -32,670,000 -39,791,000 -55,570,000 -57,183,000 -72,971,000 
      proceeds from sale of investments
    		0 0 19,011,000                                                               
      proceeds from sale of property, plant and equipment
    		93,000 65,000 182,000                                                          207,000 1,526,000 168,000 200,000 -143,000 
      purchase of investments
    		                                                                 
      other investing activities
    		-101,000 -198,000 108,000 12,000 -93,000 -22,000 -172,000 -100,000 -9,000 -275,000 -1,552,000 -146,000 -390,000 2,000 -453,000 170,000 -392,000 -615,000 1,771,000 -811,000 -219,000 -707,000 350,000 89,000 -443,000 -766,000 319,000 -1,051,000 39,000 -478,000 146,000 362,000 210,000 -149,000 193,000 119,000 3,310,000 34,000 -7,000 2,181,000 -3,383,000 -112,000 -211,000 736,000 573,000 639,000 -1,574,000 -846,000 148,000 -150,000 3,688,000 -11,876,000 475,000 6,000 -4,935,000 -4,105,000 -541,000 -115,000 -188,000 1,590,000 404,000 1,380,000 880,000 2,201,000 -238,000 
      net cash from investing activities
    		-15,747,000 -19,620,000 1,345,000 -14,615,000 -13,403,000 -15,293,000 -15,748,000 1,891,000 -6,914,000 -10,807,000 -11,197,000 -8,224,000 -12,361,000 -10,327,000 -5,592,000 6,989,000 -1,713,000 -6,150,000 -4,301,000 3,278,000 16,823,000 -3,448,000 -10,615,000 -6,488,000 -28,700,000 -39,528,000 -31,726,000 -43,166,000 -39,133,000 -38,796,000 -67,551,000 -22,898,000 -8,976,000 -11,600,000 -4,619,000 -5,149,000 -2,417,000 -4,698,000 -1,992,000 -20,040,000 -25,298,000 -23,300,000 -46,349,000 -34,258,000 -866,219,000 -22,515,000 -44,747,000 -28,267,000 -21,318,000 -73,107,000 -74,268,000 -13,261,000 -84,571,000 172,723,000 -28,052,000 -35,543,000 -46,527,000 -22,846,000 -10,970,000 -8,128,000 -35,868,000 -51,690,000 -54,013,000 -54,723,000 -73,370,000 
      financing activities:
    		                                                                 
      proceeds from credit agreements and long-term debt
    		98,000 98,000 96,000 98,000 109,000 157,000 184,456,000 145,000 215,000                                                         
      principal payments on credit agreements and long-term debt
    		-98,000 -98,000 -96,000 -98,000 -109,000 -157,000 -163,215,000 -2,056,000 -204,000                                                         
      payments on financing lease obligations
    		-1,348,000 -1,139,000 -931,000  -414,000 -363,000 -277,000  -148,000 -431,000 -258,000  0                                                     
      debt issuance costs
    		   -692,000 0                      -155,000 6,715,000 -10,051,000                                     
      shares withheld for taxes on equity-based compensation
    		-619,000 -76,000 -1,158,000 -53,000 -566,000 -48,000 -2,339,000                                                           
      other financing activities
    		0   0 0                                 -2,089,000 -6,000  -6,000       -1,224,000 -447,000                 
      net cash from financing activities
    		-1,967,000 -2,495,000 -2,089,000 -1,129,000 -980,000 -2,370,000 13,348,000 -2,769,000 -137,000 -6,893,000 5,136,000 2,811,000 3,000 -3,496,000 722,000 -11,398,000 -8,881,000 112,000 -29,887,000 -7,853,000 -3,290,000 -7,624,000 1,138,000 -17,380,000 -7,260,000 -2,597,000 21,312,000 -15,614,000 5,114,000 -20,116,000 185,610,000 -174,000 -30,670,000 1,475,000 8,033,000 -14,740,000 9,096,000 -4,772,000 -20,538,000 -58,867,000 -26,530,000 -23,676,000 5,636,000 -9,647,000 854,953,000 25,383,000 955,000 32,826,000 5,334,000 -3,025,000 1,534,000 -1,038,000 -64,000 48,641,000 3,194,000 -6,998,000 73,000 466,000 551,000 -101,752,000 13,152,000 -29,635,000 22,513,000 29,116,000 -2,586,000 
      effect of exchange rate changes on cash
    		-255,000 1,533,000 651,000 -1,696,000 774,000 -355,000 -330,000 662,000 -772,000 320,000 167,000 749,000 -872,000 -565,000 236,000 -136,000 -739,000 407,000 -1,303,000 1,160,000 471,000 114,000 -940,000 407,000 -711,000 272,000 -167,000 -39,000 -203,000 1,117,000 -96,000 589,000 3,000 418,000 112,000 -797,000 -453,000 -782,000 45,000 -1,238,000 -700,000 54,000 -970,000 -634,000 -1,405,000 -151,000 -730,000 -230,000 602,000 355,000 1,337,000 -1,581,000 -2,720,000 382,000 1,612,000 -218,000 2,475,000 -1,405,000 -417,000 99,000 971,000 1,681,000 -133,000 -2,517,000 -1,595,000 
      increase in cash and cash equivalents
    		-1,603,000 27,751,000 3,842,000 -11,805,000 6,261,000 6,813,000 -16,546,000 18,659,000 6,151,000 10,992,000 3,091,000   3,481,000 1,300,000  -8,516,000 -3,849,000 -29,666,000  18,444,000 27,253,000 11,759,000  9,934,000 -10,888,000 -3,169,000  -20,462,000 -38,661,000 86,702,000 5,278,000 -2,248,000 10,270,000 -17,012,000 7,630,000 -1,707,000         7,267,000 -8,452,000 10,078,000 -1,836,000 -72,187,000 -83,013,000 -20,476,000 -98,886,000 251,293,000 7,121,000 -8,794,000 -15,073,000 14,817,000 41,016,000 25,237,000 -14,439,000   -18,055,000  
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 37,208,000                                                               
      cash, cash equivalents and restricted cash at end of period
    		-1,603,000 27,751,000 41,050,000                                                               
      reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets
    		                                                                 
      cash and cash equivalents at end of period
    		-1,603,000 27,749,000 41,000,000 -11,368,000 10,642,000 1,774,000 35,939,000 18,659,000 6,151,000 10,992,000 16,683,000                     5,278,000 -2,248,000 10,270,000 12,828,000 7,630,000 -1,707,000 -1,916,000 25,833,000 -2,421,000 -16,463,000 7,425,000 34,516,000 12,169,000 -1,354,000 7,267,000 30,302,000 10,078,000 -1,836,000 -72,187,000 121,399,000 -20,476,000 -98,886,000 251,293,000 72,481,000 -8,794,000 -15,073,000 14,817,000 74,410,000 25,237,000 -14,439,000 10,491,000 12,105,000 -18,055,000 -11,911,000 
      restricted cash at end of period
    		0 2,000 50,000 -437,000 -4,381,000                                                             
      total cash, cash equivalents and restricted cash at end of period shown in the consolidated statements of cash flows
    		-1,603,000 27,751,000 41,050,000                                                               
      (gain) loss on investments
    		      -2,795,000                                                           
      benefit from deferred income taxes
    		                                                          343,000  4,166,000 4,018,000 4,759,000  5,801,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                 
      depreciation, amortization, and accretion
    		   9,354,000 8,837,000 8,775,000 8,755,000 8,624,000 8,578,000 8,457,000 8,670,000 8,758,000 8,634,000 7,748,000 7,679,000 8,008,000 8,309,000 8,234,000 8,981,000 29,841,000 29,604,000 29,842,000 29,460,000 30,914,000 30,919,000 31,818,000 30,627,000 30,045,000 29,460,000 28,996,000 28,509,000 28,861,000 29,200,000 28,620,000 29,478,000 30,598,000 31,852,000 33,539,000 33,606,000 38,696,000 38,909,000 39,068,000 38,342,000  33,234,000 22,007,000 23,040,000  20,751,000                 
      benefit for deferred income taxes
    		                   -362,000 83,000 412,000 55,000 -842,000 -5,000 321,000 229,000 -51,000 -557,000 -219,000 -61,000 -2,617,000 -115,000 -310,000 -6,000 -806,000 -469,000 -866,000 333,000 -2,122,000 2,696,000 -1,075,000 122,000 26,883,000 -14,301,000 -4,764,000 -8,168,000 -7,901,000 2,845,000 653,000 -1,200,000 -16,998,000 1,487,000 13,152,000 -3,398,000 -43,301,000 -969,000         
      benefit from credit losses
    		        -530,000                                                         
      insurance recoveries associated with damaged equipment
    		        0 0 -2,850,000  0 0 -3,750,000  0 0 110,000  -52,000           0                                  
      changes in operating assets and liabilities, net of assets acquired:
    		                                                                 
      purchases of property, plant, and equipment
    		   -14,888,000 -14,573,000 -15,392,000 -15,827,000 -7,912,000 -6,966,000 -10,490,000 -12,784,000 -7,378,000 -12,266,000 -11,107,000 -9,305,000 -5,913,000 -2,131,000 -5,728,000 -6,761,000 -7,375,000 -2,403,000 -7,218,000 -12,390,000 -19,081,000 -28,588,000 -28,195,000 -32,409,000 -34,851,000 -39,639,000 -38,549,000 -28,892,000 -23,336,000 -11,944,000 -11,583,000 -5,060,000 -5,628,000 -6,442,000 -5,765,000 -3,231,000 -24,454,000 -22,874,000 -24,245,000 -49,024,000 -47,474,000 -31,895,000 -23,405,000 -28,835,000 -27,824,000 -22,020,000 -30,120,000 -25,764,000 -23,747,000 -63,573,000 -16,965,000 -19,319,000 -25,496,000 -48,322,000 -23,020,000 -10,846,000       
      acquisition of businesses
    		                                                                 
      purchases of investments
    		                                                                 
      proceeds from sale of property, plant, and equipment
    		   261,000 2,284,000 121,000 251,000 6,003,000 161,000 208,000 289,000 217,000 295,000 778,000 416,000                                     430,000 459,000   308,000 2,336,000 289,000 64,000       
      proceeds from insurance recoveries associated with damaged equipment
    		       0 0 0 2,850,000 0 0 0 3,750,000                                                   
      payments on finance lease obligations
    		                                                                 
      cash and cash equivalents at beginning of period
    		   0 0 0 52,485,000 0 0 0 13,592,000 0                    0 0 0 29,840,000 0 0 0 23,057,000 0 0 0 48,384,000 0 0 0 38,754,000 0 0 0 204,412,000 0 0 0 65,360,000 0 0 0 33,394,000 0 0 0 3,882,000 0 0 
      cash, cash equivalents, and restricted cash at end of period
    		   -11,805,000 6,261,000                                                             
      reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
    		                                                                 
      total cash, cash equivalents, and restricted cash at end of period shown in the consolidated statements of cash flows
    		   -11,805,000 6,261,000                                                             
      (recovery of) benefit from credit losses
    		    130,000                                                             
      other non-cash charges
    		             -212,000 -101,000  -270,000 -84,000 14,000                                               
      impairment and other charges
    		        0    0    0    97,000 8,977,000 5,371,000  849,000 2,311,000 146,000                                       
      expense unamortized finance costs
    		      5,535,000                                                           
      debt issuance costs and other financing activities
    		      -5,277,000         -111,000 -625,000 -357,000 -98,000 -2,116,000 -1,393,000 -2,269,000 -235,000 -62,000 -48,000      -6,139,000  -282,000 -1,172,000 -119,000                               
      gain on sale on disposal of discontinued operations
    		                                                                 
      unrealized (gain) loss on investments
    		                                                                 
      realized gain on sale of standard lithium shares
    		                                                                 
      provisions for deferred income taxes
    		                                                                 
      benefit from (recovery of) credit losses
    		          -21,000                                                       
      gain from insurance recoveries associated with damaged equipment
    		                                                                 
      other non-cash charges and credits
    		                               193,000 77,000 197,000 -532,000 -1,242,000 409,000 3,150,000 -593,000 5,436,000 -1,056,000 374,000 -483,000 958,000 1,500,000 59,000 -3,331,000 -2,175,000 -2,728,000 6,126,000 778,000 -39,536,000 14,724,000 13,010,000 6,987,000 43,938,000 7,698,000 5,347,000 -2,977,000 6,416,000 7,555,000 9,213,000 1,859,000 -5,259,000 -1,276,000 
      acquisition of businesses, net of cash acquired
    		                       0 -607,000   -7,628,000 0 0 -42,002,000             0 -835,694,000 0 -18,337,000                   
      purchase of carbonfree convertible note
    		                                                                 
      proceeds from sale of investment
    		                                                                 
      cash and cash equivalents at beginning of period associated with discontinued operations
    		               0 0 0 16,577,000                                               
      cash and cash equivalents at beginning of period associated with continuing operations
    		           0                                                      
      loss on investments
    		                                                                 
      benefit for deferred taxes
    		                                                                 
      purchase of investment
    		                                                                 
      proceeds from long-term debt and credit agreements
    		          52,756,000                                                       
      principal payments on long-term debt and credit agreements
    		          -47,362,000                                                       
      benefit from (recovery of) doubtful accounts
    		                                                                 
      csi compressco debt exchange expenses
    		                                                                 
      proceeds from long-term debt
    		           12,130,000 28,000 134,000 1,533,000    160,000 73,587,000 65,717,000 281,831,000 56,512,000 36,500,000 52,000,000 128,090,000 66,000,000 20,000,000 239,637,000 33,700,000 474,550,000 87,450,000 118,400,000 104,150,000 74,550,000 91,080,000 86,200,000 163,700,000 117,600,000 242,900,000 89,125,000 151,917,000 51,954,000 77,483,000 683,586,000 65,100,000 11,350,000 57,496,000 18,030,000 -5,000 1,952,000     90,000,000 0 0 35,000       
      principal payments on long-term debt
    		           -9,191,000 -25,000 -2,456,000 -811,000 -13,000,000 -8,157,000 180,000 -29,500,000 -78,908,000 -67,302,000 -286,853,000 -54,511,000 -53,499,000 -50,501,000 -118,766,000 -35,451,000 -36,973,000 -219,662,000 -47,150,000 -278,150,000 -82,850,000 -144,700,000 -97,400,000 -59,150,000 -204,332,000 -134,950,000 -219,550,000 -130,951,000 -289,125,000 -105,900,000 -165,716,000 -37,329,000                       
      distributions to csi compressco public unitholders
    		                                                                 
      increase in cash and cash equivalents and restricted cash
    		                                                                 
      cash and cash equivalents at end of period associated with discontinued operations
    		                                                                 
      cash and cash equivalents at end of period associated with continuing operations
    		           -11,655,000                                                      
      gain on gp sale
    		                0 0 -120,574,000                                               
      benefit from doubtful accounts
    		            -213,000 183,000 61,000     950,000 403,000 4,124,000 1,380,000 1,688,000 2,429,000 295,000 627,000 590,000 901,000 212,000 453,000 95,000 89,000 472,000 772,000 113,000 990,000 1,135,000 198,000 1,279,000 2,754,000 1,112,000 242,000 204,000      -394,000 90,000        -1,318,000   1,134,000 602,000   
      warrants fair value adjustment
    		                -3,164,000 2,698,000 323,000 75,000 0 11,000 -337,000 -589,000 78,000 -1,520,000 407,000 -11,151,000 -179,000 2,196,000 -1,995,000 6,267,000 -47,000 -5,545,000 -5,976,000                               
      proceeds from gp sale, net of cash divested
    		                                                                 
      repurchase of common stock
    		                  -449,000                                               
      decrease in cash and cash equivalents
    		                                      2,776,000  -16,463,000                      8,223,000   
      cash and cash equivalents and restricted cash at beginning of period
    		             0 31,551,000 0 0 0 83,894,000 0 0 0 17,768,000 0 0 0 40,102,000 0 0 0 26,389,000                                   
      cash and cash equivalents and restricted cash at beginning of period associated with continuing operations
    		             0 31,551,000 0 0 0 67,317,000                                               
      cash and cash equivalents and restricted cash at end of period associated with continuing operations
    		             3,481,000 32,851,000 -10,312,000 -8,516,000 -3,849,000 54,228,000                                               
      (gain on sale) or loss on disposal of discontinued operations
    		                                                                 
      impairment of goodwill
    		                                   0 0 0 106,205,000                           
      unrealized loss on csi compressco units
    		                                                                 
      (recovery of) benefit from doubtful accounts
    		                                                                 
      csi compressco series a preferred unit distributions and adjustments
    		                                                                 
      redemptions of csi compressco series a preferred
    		                                                                 
      cash and cash equivalents and restricted cash at end of period
    		               -10,312,000 -8,516,000 -3,849,000 54,228,000 8,670,000 18,444,000 27,253,000 29,527,000 -18,211,000 9,934,000 -10,888,000 36,933,000 -13,866,000 -20,462,000 -38,661,000 113,091,000                                   
      cash and cash equivalents and restricted cash at end of period associated with discontinued operations
    		                                                                 
      gain on retained csi compressco units and standard lithium shares
    		                -6,190,000 -1,621,000 -3,992,000                                               
      amortization and expense of financing costs and deferred financing gains
    		                891,000 701,000 728,000                                               
      debt-related expenses
    		                  93,000                                               
      proceeds from sale of cclp, net of cash divested
    		                548,000 0 18,000                                               
      proceeds on sale of property, plant, and equipment
    		                262,000 193,000 561,000  19,393,000 3,886,000 1,425,000  938,000 850,000 364,000  467,000 231,000 76,000  406,000 132,000 248,000  715,000 1,033,000 1,246,000  959,000 1,057,000 2,886,000  797,000 251,000 3,999,000  554,000                 
      csi compressco distributions
    		                                                                 
      tax remittances on equity based compensation
    		                   -104,000 0 -22,000 -319,000 -10,000 -113,000 -29,000 -429,000 -60,000 -115,000 -300,000 -293,000 -179,000 -217,000                                 
      dividend payments attributable to noncontrolling interest
    		                                                                 
      loss on disposal of discontinued operations
    		                                                                 
      debt exchange expenses
    		                   115,000 23,000                                             
      cclp series a preferred unit distributions and adjustments
    		                                                                 
      contingent consideration liability fair value adjustment
    		                       -200,000 0 -400,000 -400,000 -300,000 -600,000                                     
      proceeds from disposal of business
    		                           0 0 0 3,121,000                                   
      distributions to cclp public unitholders
    		                                                                 
      redemptions of cclp series a preferred
    		                       0 -8,289,000 -11,414,000 -8,346,000                                       
      proceeds from sale of common stock and exercise of stock options
    		                                                                 
      supplemental cash flow information:
    		                                                                 
      interest paid
    		                   21,736,000 7,072,000 19,706,000 15,421,000 19,259,000 15,624,000 17,905,000 15,544,000 31,610,000 6,041,000 900,000 17,710,000 6,367,000 17,203,000 8,321,000 14,395,000 6,367,000 19,436,000 8,881,000 19,822,000 21,092,000 2,981,000 12,060,000 16,358,000 23,478,000 698,000 8,487,000 429,000 7,665,000 447,000   9,072,000 0   7,822,000 2,307,000 6,710,000 2,297,000 6,923,000 2,670,000 7,312,000 3,035,000   
      income taxes paid
    		                   941,000 2,497,000 716,000 1,479,000 1,048,000 1,725,000 2,857,000 1,644,000  640,000 1,983,000 1,331,000  801,000 2,487,000 1,929,000  649,000 1,922,000 740,000  1,661,000 1,891,000 2,923,000  2,175,000 3,645,000 3,327,000  1,954,000 1,328,000 2,862,000  2,251,000 -6,667,000 -9,471,000  1,492,000 12,077,000 13,314,000  2,755,000 5,888,000 2,266,000   
      accrued capital expenditures
    		                                                                 
      loss on disposition of business
    		                                                                 
      equipment received in lieu of cash
    		                    0                                             
      cclp distributions
    		                    -312,000 -311,000 -309,000  -309,000 -308,000 -307,000 -5,296,000 -4,946,000 -4,624,000 -4,358,000 -4,011,000 -3,871,000 -3,696,000 -7,248,000 -7,314,000 -7,224,000 -7,209,000 -7,209,000 -9,527,000 -9,566,000 -9,449,000 -9,274,000                       
      reconciliation of net income to cash from operating activities:
    		                                                                 
      gain on insurance recoveries associated with damaged equipment
    		                                                                 
      non-cash loss on disposition of business
    		                           0 0 0 32,369,000                                   
      amortization of deferred financing costs
    		                        990,000 947,000 953,000 1,109,000 1,055,000 909,000 1,224,000 1,252,000 1,225,000 1,175,000 1,091,000 1,666,000 347,000 1,018,000 1,110,000 1,157,000                          
      debt financing cost expense
    		                                                                 
      cclp series a preferred redemption premium
    		                        342,000 544,000 397,000                                       
      cclp series a preferred accrued paid in kind distributions
    		                        54,000 329,000 599,000 805,000 1,095,000 1,315,000 1,523,000 1,722,000 1,809,000 1,842,000 1,955,000 1,936,000                              
      cclp series a preferred fair value adjustment
    		                        0 146,000 1,163,000 -2,077,000 498,000 -512,000 1,358,000 1,365,000 -1,137,000 -4,834,000 1,631,000 -1,891,000                              
      expense for unamortized finance costs and other non-cash charges and credits
    		                        980,000 330,000 339,000 479,000 303,000 -52,000 3,668,000                                   
      acquisition and transaction financing fees
    		                        0                   0                      
      proceeds from exercise of stock options
    		                                      28,000  63,000 -184,000 285,000  756,000 118,000 273,000  874,000 143,000 469,000  187,000 -88,000 2,333,000  49,000 340,000 392,000  -2,000 365,000 13,000  1,399,000 
      excess decommissioning/abandoning costs
    		                                              7,882,000 20,904,000 21,531,000                 
      transaction financing expenses
    		                                                                 
      gain on sale of property, plant, and equipment
    		                                                 704,000 -3,967,000               
      decommissioning liabilities
    		                               -15,000 -53,000 -23,000 -474,000 -271,000 -326,000 -64,000 -3,379,000 -5,109,000 -785,000 -3,845,000 -566,000 -23,010,000 -10,543,000 -16,459,000 -13,307,000 -14,743,000 -28,578,000 -26,858,000 -15,724,000 -35,773,000 -22,575,000 -34,322,000 -9,250,000 -20,874,000 -41,202,000 -26,804,000 -6,992,000 -7,680,000 -32,490,000 -31,005,000 -8,296,000 -3,911,000 -7,594,000 
      proceeds from issuance of common stock and warrants, net of underwriters' discount
    		                                                                 
      proceeds from cclp series a preferred units, net of offering costs
    		                                                                 
      taxes paid
    		                                                                 
      impairment of long-lived assets
    		                                    0 257,000 10,670,000                           
      cclp series a preferred offering costs
    		                                0 0 37,000                               
      impairments of long-lived assets
    		                                                   3,204,000 0 9,182,000 3,352,000 64,848,000 14,092,000 9,360,000 567,000 9,492,000 948,000     
      equity financing transaction expense
    		                                                                 
      financing costs and other financing activities
    		                                                                 
      excess decommissioning and abandoning costs
    		                                    2,000 2,756,000 37,000  780,000 -146,000 152,000  22,915,000                     
      gain on the extinguishment of debt
    		                                                                 
      proceeds from issuance of common stock, net of underwriters' discount
    		                                                                 
      net cash provided (used in) by operating activities
    		                                 19,977,000 -20,538,000                               
      equity financing transaction fees
    		                                                                 
      proceeds from issuance of cclp common units, net of underwriters' discount
    		                                                                 
      proceeds from series a preferred units, net of offering costs
    		                                                                 
      proceeds from issuance of common units, net of underwriters' discount
    		                                                                 
      excess tax benefit from equity compensation
    		                                                                 
      (gain) loss on sale of property, plant, and equipment
    		                                                   1,110,000 525,000 -59,577,000 -732,000 383,000 -544,000 157,000 93,000       
      proceeds from issuance of compressco partners' common units, net of underwriters' discount
    		                                                                 
      (decrease) in cash and cash equivalents
    		                                          -13,868,000                       
      depreciation, depletion, amortization, and accretion
    		                                                 19,221,000 17,333,000 16,818,000 16,226,000 27,755,000 34,040,000 37,242,000 38,238,000 36,275,000 36,267,000       
      excess tax benefit from equity-based compensation
    		                                                                 
      payments of long-term debt
    		                                            -159,758,000 -38,203,000 -9,423,000  -11,913,000                 
      compressco partners' distributions
    		                                            -1,300,000 -1,263,000 -1,245,000 -1,243,000 -1,210,000 -1,235,000 -1,065,000 -1,034,000              
      financing cost and other financing activities
    		                                                                 
      benefit for doubtful accounts
    		                                             131,000 -141,000      -11,000 61,000 913,000           
      business combinations, net of cash acquired
    		                                                                 
      compressco partners' offering costs
    		                                                   -709,000 0             
      supplemental disclosure of non-cash investing and financing activities:
    		                                                                 
      adjustment of fair value of decommissioning liabilities capitalized to oil and gas properties
    		                                                                 
      proceeds from issuance of compressco partners' common units,
    		                                                                 
      net of underwriters' discount
    		                                                   0 0             
      excess tax benefit from exercise of stock options
    		                                                 19,000 178,000 -2,602,000 -126,000 533,000 861,000 -791,000 24,000 126,000 124,000     88,000 -1,015,000 
      adjustment of fair value of decommissioning liabilities
    		                                                                 
      capitalized to oil and gas properties
    		                                                   14,000 -20,000 1,301,000 509,000     1,997,000      
      reconciliation of net income to cash provided (used) by operating activities:
    		                                                                 
      net cash provided (used) by operating activities
    		                                                  -11,616,000               
      acquisition of business
    		                                                  -64,528,000    -1,500,000           
      proceeds (payments) on sale of property, plant, and equipment
    		                                                  12,336,000    -2,298,000           
      proceeds from sale of derivatives
    		                                                                 
      non-cash income from sold hedge derivatives
    		                                                       -6,063,000 -5,629,000         
      proceeds from insurance settlements
    		                                                       8,000,000 0         
      deferred financing costs
    		                                                                 
      stock compensation expense
    		                                                    1,277,000 1,304,000 1,836,000 1,583,000 2,573,000 1,506,000 1,549,000 932,000 1,901,000 1,945,000 1,884,000 1,708,000 1,826,000 
      excess decommissioning/abandoning costs and
    		                                                                 
      operating activities of discontinued operations
    		                                                    0 33,000 2,000 372,000 0 -54,000 -326,000 25,000 84,000 35,000 84,000 128,000 432,000 
      business combinations
    		                                                    0        -3,809,000     
      change in restricted cash
    		                                                              509,000  -18,000 
      supplemental disclosure of non-cash investing activities:
    		                                                                 
      proceeds from insurance settlements and claims
    		                                                          39,772,000       
      equity in (earnings) loss of unconsolidated subsidiary
    		                                                           -217,000 -368,000 172,000 -97,000   
      financing and loan prepayment costs
    		                                                                 
      oil and gas properties acquired through assumption of
    		                                                                 
      proceeds from sale of cash flow hedge derivatives
    		                                                            0     
      capitalized (credited) to oil and gas properties
    		                                                          1,322,000   2,995,000 2,950,000   
      investing activities of discontinued operations
    		                                                                 
      depreciation, depletion, amortization and accretion
    		                                                            36,497,000     
      dry hole costs
    		                                                            0    2,129,000 
      (gain) loss on sale of property, plant and equipment
    		                                                            162,000 -118,000 -2,522,000   
      other operating activities
    		                                                            1,796,000     
      proceeds from long-term debt obligations
    		                                                            20,300,000 13,250,000 62,450,000  0 
      principal payments on long-term debt obligations
    		                                                            -7,146,000 -43,250,000 -39,950,000  -5,000,000 
      depreciation, depletion, accretion and amortization
    		                                                              35,855,000  38,312,000 
      impairments of oil and gas properties
    		                                                              404,000   
      gain on sale of property, plant and equipment
    		                                                               65,000  
      impairments of oil and gas properties and other long-lived assets
    		                                                                 
      equity in earnings of unconsolidated subsidiary
    		                                                                -230,000 
      trade accounts receivable
    		                                                                54,043,000 
      adjustment of fair value of decommissioning liabilities capitalized
    		                                                                 
      to oil and gas properties
    		                                                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.